Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PeptiDream | Tokyo | Healthcare | Biotechnology & Medical Research | ¥262.59B | 17.5x | 0.05 | ¥2,025.50 | -6.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
GNI | Tokyo | Healthcare | Biotechnology & Medical Research | ¥116.16B | 119.1x | -1.42 | ¥2,340 | 2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Takara Bio | Tokyo | Healthcare | Biotechnology & Medical Research | ¥103.08B | -1,980x | 18.6 | ¥854 | 2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sanbio Company | Tokyo | Healthcare | Biotechnology & Medical Research | ¥77.24B | -25.3x | -0.52 | ¥1,090 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -10.1% Downside | Upgrade to Pro+ | |
Shin Nippon Biomed Lab | Tokyo | Healthcare | Biotechnology & Medical Research | ¥60.07B | 12.2x | -1.21 | ¥1,441 | -3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Heartseed | Tokyo | Healthcare | Biotechnology & Medical Research | ¥37.54B | -33.3x | -0.84 | ¥1,750 | 3.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Healios K K | Tokyo | Healthcare | Biotechnology & Medical Research | ¥27.24B | -5.7x | -0.41 | ¥278 | 4.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.1% Upside | Upgrade to Pro+ | |
Pharma Foods | Tokyo | Healthcare | Biotechnology & Medical Research | ¥24.76B | 7.6x | -0.21 | ¥902 | 2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
AnGes | Tokyo | Healthcare | Biotechnology & Medical Research | ¥19.81B | -0.5x | 0 | ¥66 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
3-D Matrix | Tokyo | Healthcare | Biotechnology & Medical Research | ¥17.38B | -14.8x | -0.26 | ¥161 | 7.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Chordia Therapeutics | Tokyo | Healthcare | Biotechnology & Medical Research | ¥16.57B | -9.6x | 0.01 | ¥256 | 5.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
MediciNova | Tokyo | Healthcare | Biotechnology & Medical Research | ¥10.53B | -6.8x | 0.24 | ¥224 | -3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Chiome Bioscience | Tokyo | Healthcare | Biotechnology & Medical Research | ¥10.24B | -8.7x | -0.36 | ¥152 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
NanoCarrier | Tokyo | Healthcare | Biotechnology & Medical Research | ¥10.24B | -15.9x | -0.4 | ¥145 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Tsubota Laboratory | Tokyo | Healthcare | Biotechnology & Medical Research | ¥9.92B | 28.6x | 0.18 | ¥379 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
PRISM BioLab | Tokyo | Healthcare | Biotechnology & Medical Research | ¥9.71B | ¥274 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Medinet | Tokyo | Healthcare | Biotechnology & Medical Research | ¥8.99B | -1.4x | ¥34 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Cyfuse Biomedical KK | Tokyo | Healthcare | Biotechnology & Medical Research | ¥8.49B | -8.5x | 0.23 | ¥1,148 | 6.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
TMS | Tokyo | Healthcare | Biotechnology & Medical Research | ¥8.27B | -7.4x | 0.16 | ¥200 | -2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
DNA Chip Research | Tokyo | Healthcare | Biotechnology & Medical Research | ¥7.41B | -208.6x | -2.4 | ¥1,095 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Linical Co Ltd | Tokyo | Healthcare | Biotechnology & Medical Research | ¥7.41B | -31.9x | 0.24 | ¥329 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
NoileImmune Biotech | Tokyo | Healthcare | Biotechnology & Medical Research | ¥7.4B | -8.3x | -0.41 | ¥170 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
OncoTherapy | Tokyo | Healthcare | Biotechnology & Medical Research | ¥7.06B | -6.3x | -0.25 | ¥26 | -3.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Modalis | Tokyo | Healthcare | Biotechnology & Medical Research | ¥6.32B | -3.5x | -0.08 | ¥86 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Veritas In Silico | Tokyo | Healthcare | Biotechnology & Medical Research | ¥5.41B | -23.9x | 0.03 | ¥828 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Kidswell Bio | Tokyo | Healthcare | Biotechnology & Medical Research | ¥5.33B | -7.6x | ¥132 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Kringle | Tokyo | Healthcare | Biotechnology & Medical Research | ¥5.31B | -6.4x | -0.27 | ¥782 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Carna Biosciences | Tokyo | Healthcare | Biotechnology & Medical Research | ¥5.18B | -2.2x | 0.03 | ¥273 | -2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
D.Western Therapeutics Institute | Tokyo | Healthcare | Biotechnology & Medical Research | ¥5.05B | -3.2x | 0.08 | ¥118 | 3.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ribomic | Tokyo | Healthcare | Biotechnology & Medical Research | ¥4.68B | -4.2x | -0.54 | ¥106 | 6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Funpep | Tokyo | Healthcare | Biotechnology & Medical Research | ¥4.41B | -4.1x | -0.25 | ¥132 | -2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Human Metabolome Tech | Tokyo | Healthcare | Biotechnology & Medical Research | ¥4.13B | 15.6x | -2.55 | ¥695 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BrightPath Biotherapeutics | Tokyo | Healthcare | Biotechnology & Medical Research | ¥3.78B | -1x | ¥43 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
PhoenixBio Co | Tokyo | Healthcare | Biotechnology & Medical Research | ¥1.57B | -11.4x | 0.05 | ¥384 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |